This is a routine office lease for new headquarters with no impact on the company's pipeline or financial outlook. Monitor for any future updates on operational milestones or clinical data that could affect the stock.
Price Chart
Executive Summary
Bicara Therapeutics entered into a sub-sublease agreement with Wayfair LLC for approximately 35,090 square feet of office space at 10 St. James Avenue, Boston, for its new corporate headquarters. The lease runs through September 2028 with base rent of $105,279 per month starting nine months after the commencement date, and a $210,540 security deposit was paid. This is a routine administrative real estate transaction with no material financial impact on the company's operations or stock.
Key Financial Metrics
Key Facts
- Bicara Therapeutics sub-leased ~35,090 sq ft of office space at 10 St. James Avenue, Boston from Wayfair LLC.
- The sublease term runs from the later of October 1, 2026 or full consent execution, through September 30, 2028.
- Base rent is $105,279 per month, payable nine months after the Commencement Date.
- A security deposit of $210,540 was paid.
- The space will serve as the company's new corporate headquarters.
Financial Impact
Base rent of $105,279/month (~$1.26M/year) with a $210,540 security deposit. Rent payments begin nine months after the Commencement Date.
Risk Factors
- No material risks identified from this routine real estate transaction.
Market Snapshot
Investment Themes
Documents Analyzed
This report is based on 3 SEC documents filed with EDGAR.
| Document | Accession Number |
|---|---|
| 8-K Filing (Primary) | 0001628280-26-058937 |
| Document: 0001628280-26-058937-index.html | 0001628280-26-058937 |
| Document: 0001628280-26-058937.txt | 0001628280-26-058937 |
Track record builds as more directional reports settle.
Filters
| Type | Now | ||||
|---|---|---|---|---|---|
Aug 25, 2026 5w ago | 8-K | $24.73 $19.78 | ▼ −20.02% | ▼ −20.24% | $18.25 (−26.18%) |
Aug 14, 2026 7w ago | Press Release | $24.28 $23.20 | ▼ −4.45% | ▼ −2.46% | $18.25 (−24.81%) |
Aug 12, 2026 7w ago | Insider Cluster | $23.63 $22.81 | ▼ −3.47% | ▼ −1.72% | $18.25 (−22.75%) |
Aug 12, 2026 7w ago | Insider Cluster | $23.63 $22.81 | ▼ −3.47% | ▼ −1.72% | $18.25 (−22.75%) |
Aug 11, 2026 7w ago | 8-K | $23.76 $23.64 | ▼ −0.51% | ▲ +0.55% | $18.25 (−23.17%) |
Aug 11, 2026 7w ago | Press Release | $23.76 $23.64 | ▼ −0.51% | ▲ +0.55% | $18.25 (−23.17%) |
Jul 14, 2026 11w ago | Insider Cluster | $28.10 $23.76 | ▼ −15.44% | ▼ −17.94% | $18.25 (−35.04%) |
Jun 11, 2026 16w ago | Institutional Cluster | $21.28 $29.68 | ▼ −39.47% | ▼ −37.58% | $18.25 (+14.22%) |
May 26, 2026 18w ago | Insider Cluster | $21.58 $26.34 | ▲ +22.06% | ▲ +23.96% | $18.25 (−15.41%) |
May 11, 2026 20w ago | 8-K | $22.92 $20.56 | ▼ −10.30% | ▼ −9.99% | $18.25 (−20.35%) |
US Market Status
Subscribe to SecBot
Get Real-Time SEC Filing Intelligence
Comprehensive SEC filing analysis delivered the moment filings hit EDGAR. Sentiment scoring, impact analysis, and actionable insights for every material event.
Try SecBot Free Coming soon: SecBot Pro with alerts, watchlists, and API access